Biotech firm Argenx shot to an all-time high Tuesday. The gain comes amid brisk profit and sales growth for the biotech-drug maker, including a better-than-expected 664% surge in Q2 EPS on July 31, to $3.
Continue Reading
View Comments
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
Published 2 months ago
Aug 26, 2025 at 9:52 PM
Positive
Auto